Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01286311 · ClinicalTrials.gov registry record · NA
Tailored Communication to Reduce Cardiovascular Risk
A NA study, sponsored by Northwestern University.
- Completed
- Registry status
- NA
- Development phase
- 464
- Enrollment target
NCT01286311: Completed NA study, sponsored by Northwestern University.
NCT01286311 is a NA study that has completed, run by Northwestern University. The registered enrollment target is 464 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (67% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01286311, a NA study, has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- NA
- Development phase
- 464 participants
- Enrollment target
Study Summary
The primary goal of the trial is to test the feasibility and efficacy of a cardiovascular disease quality improvement system that couples EMR-based patient identification with individually tailored patient messages. The study will test the hypothesis that that a tailored patient-directed approach to cardiovascular risk reduction integrated into patients' primary care delivery site will improve control of elevated low-density lipoprotein cholesterol and other card iac risk factors more than routine care alone for patients at intermediate or high risk for cardiovascular disease.
Primary Outcome
Significant LDL cholesterol reduction at 9 months Definition: Percentage of patients with LDL-C repeated and which is at least 30 mg/dl lower than baseline
Interventions
- BEHAVIORAL Direct-to-patient tailored cardiovascular risk message system
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 464 participants |
| Start Date | 2011-01 |
| Est. Completion | 2013-01 |
| Phase | NA |
What the finished NCT01286311 record still lists
NCT01286311 is an interventional study that assigns participants to a tested intervention. The registered 464 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (67% lower).
The record links to 0 conditions, and to 1 intervention - of which Direct-to-patient tailored cardiovascular risk message system is the first listed.
NCT01286311 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01286311 about?
NCT01286311 is a clinical study titled "Tailored Communication to Reduce Cardiovascular Risk". The primary goal of the trial is to test the feasibility and efficacy of a cardiovascular disease quality improvement system that couples EMR-based patient identification with individually tailored patient messages. The study will test the hypothesis that that a tailored patient-directed approach to...
What is the current status of trial NCT01286311?
This trial is currently completed. It is a NA study. The enrollment target is 464 participants. The study started on 2011-01. Estimated completion is 2013-01.
What interventions are being tested in trial NCT01286311?
The interventions under investigation include: Direct-to-patient tailored cardiovascular risk message system (BEHAVIORAL).
Who is sponsoring clinical trial NCT01286311?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01286311's enrollment target sits among peer trials
464 222nd of 2000 higher than 1,779 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04787744 · 464 participants · Phase 2
Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer
- NCT04855656 · 464 participants · Phase 1
Study of Lunresertib Alone or in Combination With RP-3500 or Debio 0123 in Patients With Advanced Solid Tumors
- NCT06283927 · 464 participants
The RECSUR-study: Resection Versus Best Oncological Treatment for Recurrent Glioblastoma (ENCRAM 2302)
- NCT06444295 · 464 participants · NA
Testing the Impact of Thrive App Versions on Alcohol Use and Posttraumatic Stress After Recent Sexual Assault
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia